Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canal

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|April 1, 1996
[Dose optimization in clinical oncology: pharmacokinetic-pharmacodynamic relationship]P Canal, E Chatelut
Pathologie-Biologie|December 1, 1982
Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?P Canal, G Soula
L' Information Dentaire|June 29, 1989
[Preprosthetic orthodontics]P Canal, R Garcia
Drugs|January 8, 1999
Practical treatment guide for dose individualisation in cancer chemotherapyP Canal, E Chatelut, S Guichard
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melaninF Laurent, P Canal, G Soula
Bulletin Du Cancer|November 18, 2000
[Pharmacokinetics and individual dose adjustment of carboplatin]E Chatelut, P Canal, R Bugat
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1985
Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretionG Akel, P Canal, G Soula
Revue D'Orthopedie Dento-Faciale|January 1, 1988
[Removal of bonded orthodontic brackets: protocol for tooth polishing]P Miara, S Lustman-Rozencweig, P Canal
Mondo Ortodontico|November 1, 1988
[Temporomandibular dysfunction: therapeutic approach]P Canal, J P Curiel, P Monsénégo
Biochemical Pharmacology|March 27, 1998
Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell lineS Guichard, I Hennebelle, R Bugat, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|April 1, 1996
[Dose optimization in clinical oncology: pharmacokinetic-pharmacodynamic relationship]P Canal, E Chatelut
Pathologie-Biologie|December 1, 1982
Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?P Canal, G Soula
L' Information Dentaire|June 29, 1989
[Preprosthetic orthodontics]P Canal, R Garcia
Drugs|January 8, 1999
Practical treatment guide for dose individualisation in cancer chemotherapyP Canal, E Chatelut, S Guichard
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melaninF Laurent, P Canal, G Soula
Bulletin Du Cancer|November 18, 2000
[Pharmacokinetics and individual dose adjustment of carboplatin]E Chatelut, P Canal, R Bugat
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1985
Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretionG Akel, P Canal, G Soula
Revue D'Orthopedie Dento-Faciale|January 1, 1988
[Removal of bonded orthodontic brackets: protocol for tooth polishing]P Miara, S Lustman-Rozencweig, P Canal
Mondo Ortodontico|November 1, 1988
[Temporomandibular dysfunction: therapeutic approach]P Canal, J P Curiel, P Monsénégo
Biochemical Pharmacology|March 27, 1998
Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell lineS Guichard, I Hennebelle, R Bugat, et al.
Pageof 15